Matthew Wikler - 31 Dec 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Director
Signature
/s/ Keith A. Kucinski, attorney-in-fact for Matthew Wikler
Issuer symbol
MTNB
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 16:45:54 UTC
Previous filing
02 Nov 2021
Next filing
16 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock Award $0 +7,859 +2.8% $0.000000 290,472 31 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant.